Key Highlights
- Min Park brings 25+ years of experience in global commercial operations.
- Previously held leadership roles at top CDMOs, including WuXi and Samsung Biologics.
- Focuses on creating a customer-centric CDMO for advancing lifesaving therapies.
- Chairman of NAAAP and holds advanced degrees in science and international business.
Source: Business Wire
Notable Quotes
- “We are excited to welcome Min Park to Matica Bio’s executive team. He has a wealth of experience in leading commercial teams and commercial strategy with customer value generation in mind.” — Paul Kim, CEO at Matica Bio
- “I’m excited to join Matica Bio’s team to create a customer-centric cell and gene therapy CDMO to support our partners to accelerate more lifesaving therapies from idea to patient.” — Min Park, Chief Commercial Officer at Matica Bio
SoHC's Take
Min Park’s appointment is a strategic move by Matica Biotechnology to strengthen its position in the highly competitive CDMO market. His extensive track record in launching global operations and driving commercial success aligns seamlessly with Matica Bio’s mission to support groundbreaking cell and gene therapies. By emphasizing a customer-centric approach and leveraging cutting-edge technologies, Matica Bio is well-positioned for sustained growth and impact in the life sciences industry.
